Answers are grounded in this paper and cite their sources.
Experimental study reveals broad multistage antimalarial activity of 4-quinolone derivatives against Plasmodium parasites, suggesting their therapeutic potential as transmission-blocking agents.
High Resolution Image Download MS PowerPoint Slide Malaria is a critical global health problem, with high mortality and morbidity rates, which ultimately hinder socioeconomic development in endemic areas. The evolution of drug resistance in malaria parasites, particularly in the case of Plasmodium falciparum, and the scarcity of effective drugs both for case management and for blocking transmission contribute to the aggravating malaria's burden. The present study sought to evaluate the potential of novel 4-quinolone derivatives as multistage antimalarials with predicted activity against asexual intraerythrocytic, liver, and transmission-blocking stages. We show that compound 1, a natural 2-substituted-4-quinolone, previously isolated from plants and microorganisms, and its derivatives 2 – 6, displayed significant activity against Plasmodium sexual stages in both ex vivo and in vivo assays and effectively prevented hepatic cell infections, with compound 1 displaying the highest activity against both sexual and asexual stages. Collectively, we conclude that these compounds warrant further studies toward the development of new antimalarial drugs.
No takes yet. Share an insight, caveat, or question.
Annunciato et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: